Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-066-7 | CAS number: 1472633-72-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- other: an assessment of toxicokinetic behavior has been conducted to the extent that can be derived from the relevant available information.
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Relevant studies were reviewed with a view to fulfilling the requirements of Annex VIII (8.8.1).
Data source
Reference
- Reference Type:
- other: an assessment of toxicokinetic behaviour has been conducted to the extent that can be derived from the relevant available information.
- Title:
- Unnamed
- Year:
- 2 013
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- In accordance with REACH Annex VIII (8.8.1) an assessment of toxicokinetic behavior has been conducted to the extent that can be derived from the relevant available information.
Test material
- Reference substance name:
- 2-({bis[(1,3-dihydroxypropan-2-yl)oxy]boranyl}oxy)propane-1,3-diol
- EC Number:
- 700-066-7
- Cas Number:
- 1472633-72-9
- Molecular formula:
- C9H21BO9
- IUPAC Name:
- 2-({bis[(1,3-dihydroxypropan-2-yl)oxy]boranyl}oxy)propane-1,3-diol
Constituent 1
Results and discussion
Any other information on results incl. tables
Toxicokinetic behaviour.
The reference substance (BAGE) is unstable in water and hydrolyses within less than an hour to its hydrolysis products: Boric acid and glycerol.
Boric acid is considered to be the hydrolysis product of main concern, due to its known reproduction/developmental effects so the following assessment is made on boric acid, based on available data.
Boric acid is anticipated to be present under standard physiologically conditions.
Glycerol is not classified for human health according to CLP or DSD and is essentially non-toxic. Further toxicokinetic evaluation of glycerol has not been assessed.
Boric acid:
Absorption:
The molecule size and high water solubility of boric acid suggests that absorption across the gastro-intestinal tract may occur and provide a route of potential absorption following oral administration, potentially facilitating systemic distribution.
Results of the oral feed OECD Guideline 414 Prenatal Developmental Toxicity Study show evidence to support the absorption of boric acid.
Absorption may occur via the inhalation route. Acute inhalation studies showed no mortality but some clinical signs were noted in animals, indicating some absorption may have occurred. However, due to the low volatility of boric acid, inhalation is not considered to be a significant route of exposure.
Limited dermal absorption may potentially occur via the skin due to molecular size and water solubility of boric acid. However, an acute dermal toxicity study showed no mortality and only minor clinical effects, and a skin irritation study showed minimal irritation, indicating that dermal absorption is not significant.
Distribution:
Once absorbed, boric acid may be distributed systemically due to it's high solubility (i.e. in blood plasma). The reproduction/development effects of boric acid support systemic distribution.
The negative result for skin sensitisation suggests boric acid will not bind to carrier proteins in the circulatory systems.
The low octanol/water partition coefficient and high water solubility of boric acid indicates it is not lipophilic and would not accumulate in fatty tissues.
Metabolism:
There is no evidence to indicate boric acid influences hepatic metabolism.
The results of in-vitro genotoxicity studies do not show any evidence that the addition of a metabolising system enhanced or diminished the genotoxic potential of the substance.
Excretion:
As boric acid is highly water soluble it is anticipated that this would facilitate urinary excretion.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): low bioaccumulation potential based on study results
The available information on boric acid suggests absorption from the gastro-intestinal tract can occur. Once absorption occurs, boric acid may be systemically distributed. Urine is likely to be the significant route of excretion. Limited bioaccumulation is anticipated basesd on the low partition coefficient and high water solubility.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
